Facebook
X
LinkedIn
ForwardHead & Neck Oncology Symposium 2025
Live In-Person Only
The incidence of head and neck cancer in the United States is expected to increase by 12% from 2020 till 2030 (CDC USCS Data). While head and neck cancer accounts for only 4% of all cancers in the United States, the extensive treatment modalities, severe impact on daily living, and high recurrence rate make head and neck cancer one of the most complex oncologic subspecialties to develop within the hospital (American Cancer Society). Clinicians need up to date knowledge of care management for patients with head and neck cancer. We will educate on updates in surgical advances, chemotherapy and immunotherapy developments, clinical trials, radiation therapy, and technology evolution for reconstruction. In addition to covering clinical advancements, we will educate on the multidisciplinary team that is vital to the treatment of head and neck cancer patients. The responsibilities of surgeons, radiation oncologists, medical oncologists, pathologists, social workers, nurse navigators, speech and language pathologists, and maxillofacial prosthodontics will be covered at length with panels teaching how to create highly-effective and collaborative multidisciplinary teams.
Target Audience
Clinicians caring for head and neck cancer patients, including but not limited to: ENT, Oral and Maxillofacial Surgeons, Endocrinologists, Speech Language Pathologists, Nurse Navigators, Radiation Oncologists, Medical Oncologists, Pathologists, Head & Neck Surgeons, Dentists, Medical Residents, Social Workers, Fellows in Oncologic Specialties.
Learning Objectives
Upon conclusion of this symposium, learners should be able to:
- Diagnose, manage, and treat salivary and neoplasms cancers (head and neck cancer) with the multidisciplinary care team to improve patient experience and outcomes.
- Apply new advancements in the care management of oral and oropharyngeal cancers including multidisciplinary treatment and collaboration.
- Integrate survivorship into the post treatment algorithm to ensure psychosocial and quality of life endpoints are incorporated into the patients care.
All agenda session times are listed in Mountain Standard Time (MST)
Day 1
Day 1, Friday, November 7, 2025
| TIMES | AGENDA | SPEAKER(S) |
|---|---|---|
| 7:30 a.m. | Breakfast | Moderator: David Neskey, MD, MSCR, FACS |
| 8:20 a.m. | Opening Remarks | Joshua Hornig, MD, FRCSC and Jeff Wilson, CEO, Trident Health |
| 8:30 a.m. | Proliferative Verrucous Leukoplakia of the Oral Mucosa | Ricardo Padilla, DDS |
| 8:40 a.m. | Medical Oncology Advice for the Surgical Oncologist Panel | Moderated by Joshua Dean Horton, MD; Panelists - Matthew Beldner, MD, Terry A. Day, MD, FACS, Richard O'Neal, MD, Cesar A. Perez, MD |
| 9:05 a.m. | Virtual Surgical Planning and Patient-Specific Plating in Head and Neck Reconstruction | Urjeet A. Patel, MD, FACS |
| 9:25 a.m. | Head and Neck Reconstruction: Challenging Cases Panel | Moderated by Thomas Hendriks, MBBS, MPhil, FRACS and Usman Khan, MD, MSc, FRCSC; Panelists - James R. Bekeny, MD, Betsy K. Davis, DMD, MS, Joshua Hornig, MD, FRCSC, Shaum Sridharan, MD |
| 9:50 a.m. | Beyond Oncologic Success: Should Functional Laryngectomy Be Routinely Considered? | Ali Fanuochi, MS, CCC-SLP and Laura McWilliams MS, CCC-SLP, BCS-S, CPHFH |
| 10:10 a.m. | Break | Moderator: Peter Horwich, MEd, MD, FRCSC |
| 10:25 a.m. | Beyond Head and Neck Treatment: Supporting Patients through their Care Panel | Moderated by Shimrit Sharav, MD; Panelists - Vincent Grzywacz, MD, Stephanie Herlong, MS, CCC-SLP, Sara Jasper, ACNP-BC, Julie Molony, BSN, RN |
| 10:50 a.m. | Rewriting the Endgame: The Evolving Landscape of Recurrent/Metastatic Oropharyngeal Squamous Cell Carcinoma | R. Alex Harbison, MD, MS |
| 11:10 a.m. | Keynote Speaker: A Patient-Centered Approach to Head and Neck Cancer Care | Michael G. Moore, MD, FACS |
| 11:45 a.m. | Pathology is Your Friend: Standardizing Lymph Node Grossing in Head and Neck Pathology | John W. Tumer, MD, MBA, FCAP |
| 11:55 a.m. | Reconstructive Debates | Andrew T. Huang, MD, FACS and Shaum Sridharan, MD |
| 12:20 p.m. | Winning in Head and Neck Cancer Care: Perspectives Beyond the Clinician Panel | Moderated by Dax Kurbegov, MD, FASCO; Panelists - Le-An King, CPC, Jeff Wilson |
| 12:45 p.m. | Surgical Management of Skin Cancers Panel | Moderated by Peter Horwich, MEd, MD, FRCSC; Panelists - David Forner, MD, MSc, FRCSC, Eric Lentsch, MD, FACS, Michael Dale Sarradet, MD, Anand K. Sharma, MD |
| 1:10 p.m. | Adjourn and Lunch with the Experts on Veranda | |
| 5:30 p.m. | Welcome Reception and Dinner |
Day 2
Day 2, Saturday, November 8, 2025
| TIME | EVENT/TOPIC | SPEAKER(S) |
|---|---|---|
| 7:30 a.m. | Breakfast | Moderator: Jeffrey Houlton, MD |
| 8:30 a.m. | Opening Remarks | Jeffrey Houlton, MD |
| 8:35 a.m. | Complicated Endocrine Case Files Panel | Moderated by Joshua Hornig, MD, FRCSC; Panelists - Joseph Mathews MD, FACP, FACE, ECNU, CCD, Urjeet A. Patel, MD, FACS, Russell Smith, MD |
| 9:00 a.m. | Surgical Management of Parotid Cancer | Michael G. Moore, MD, FACS |
| 9:20 a.m. | Our Experience With the Pre-Prosthetic Design for Obturator Retention | Michelle K. Ruse, DDS, MDS, FACP |
| 9:30 a.m. | The Evolving Role of cDNA in the Management of Head and Neck Cancer | Scott A. Roof, MD, MS |
| 9:50 a.m. | Break | Moderator: Joshua Hornig, MD, FRCSC |
| 10:05 a.m. | Keynote Speaker: On the Edge of Change: Investigational Agents in Head and Neck Cancer and the Evolution of Patient Care | Cesar A. Perez, MD |
| 10:40 a.m. | Oral Surgery Case Files Panel | Moderated by Jeffrey Houlton, MD; Panelists - Paul L. Davis III, MD, FACS, Brad W. Neville, DDS, Michael H. Porter, DDS, John W. Ratliff, DDS |
| 11:05 a.m. | Management of Oropharyngeal Cancer Panel | Moderated by David Neskey, MD, MSCR, FACS; Panelists - R. Alex Harbison, MD, MS, Scott A. Roof, MD, MS, Anthony Sanchez, MD, Anand K. Sharma, MD. Hannah Cornett Walton, MS, CCC-SLP, BCS-S |
| 11:30 a.m. | (Shared) Decision Making in Head and Neck Cancer | David Forner, MD, MSc, FRCSC |
| 11:50 a.m. | A Patient Story | Lindsey Kim |
| 1210 p.m. | Closing Remarks | Jeffrey Houlton, MD |
Please click here for more information regarding the venue
Head Neck Oncology Symposium- Know Before You Go.pdf
Travel
Please see the below information for our room blocks at Wild Dunes Resort, SC, for November 7th through the 8th, 2025.
It is important to make hotel reservations by Thursday, October 16th, 2025 as the discounted rate will end thereafter. If you have trouble with the booking website, wish to book outside of the contracted dates or make requests for your reservation will need to call the Toll Free Reservation Number listed on the hotel website and inform the customer service representative that you are booking through the Head & Neck Cancer Symposium Group Rate.
Wild Dunes Resort
Address: 5757 Palm Blvd, Isle of Palms, SC 29451
Call to reserve: 866-359-5593, Option 2 or 877-624-3654.
Last Day to Book for discounted rate: October 16,2025
Link to book: Head & Neck Cancer Symposium Booking Link
Group Name/Code: Head & Neck Cancer Symposium/ G-A4Z0
For general conference questions please contact:
Chris Childress - Oncology Administrator, Trident Health
Margaret King - Program Coordinator
For CME Related questions please contact:
[email protected]
Speaker
Betsy Davis, DMD
Speaker
National Director, Maxillofacial Prosthodontics and Dental Oncology
Sarah Cannon Cancer Institute
HCA Healthcare Trident's Head and Neck Specialists
Peter Horwich, M.Ed, MD, FRCSC
Speaker
Director of Head and Neck Surgical Oncology
Clinical Operation and Improvements
Jeffrey Houlton, MD
Course Director, Speaker
Surgeon
Assistant Professor of Head and Neck Surgery
UW Medicine's Head and Neck Surgery Center
Eric Lentsch, MD, FACS
Speaker
Director of Minimally Invasive Surgery
Head and Neck Specialists
Charleston, SC
Michelle Ruse, DDS, MDS, FACP
Speaker
Maxillofacial Prosthodontist
Head and Neck Specialists
Charleston, SC
Scott A. Roof, MD, MS
Speaker
Assistant Professor
Director of Clinical Research
Division of Head and Neck Oncology and Microvascular Surgery
Department of Otolaryngology – Head and Neck Surgery
Icahn School of Medicine at Mount Sinai
Course Planners
Tammy Gage
Planner
Program Coordinator
System Office of Continuing Medical Education and EMS Education
HCA Healthcare, Continental Division
Stacy Weiss, PhD
Planner
Assistant Vice President,
System Office of Continuing Medical Education and EMS Education,
HCA Continental Division
James Bekeny, MD
Matthew Beldner, MD
Hannah Cornett, MS, CCC-SLP, BCS-S
Paul Davis, MD
Alicia Fanucchi, MS, CCC-SLP
David Forner
Vincent Grzywacz, M.D.
Richard Harbison, MD, FACS
Thomas Hendriks, MBBS, MPhil, FRACS
Stephanie Herlong
Andrew Huang, MD FACS
Sara Jasper, ACNP
Usman Khan
Le-An King, CPC
Dax Kurbegov, MD, FASCO
Joseph Mathews, MD, FACP, FACE, ECNU, CCD
Laura McWilliams, MS CCC-SLP, BCS-S, CPHFH
Juliana Molony
Michael Moore, MD
Brad Neville, DDS
Richard O'Neal, MD
Ricardo Padilla, DDS
Cesar Perez, M.D
Michael Porter, DDS, Board Certified Oral and Maxillofacial Surgeon
John Ratliff, DDS
Anthony Sanchez, MD
Michael Sarradet, MD
Shaum Sridharan, Associate Professor, Department of Otolaryngology - Head & Neck Surgery
John Turner
Jeffrey Wilson, BA, MSHA
Accreditation:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of HCA Healthcare Continental Division and HCA Healthcare South Atlantic Division. HCA Healthcare Continental Division is accredited by the ACCME to provide continuing medical education for physicians
Credit Designation:
The HCA Healthcare Continental Division designates this live activity for a maximum of 7.0 AMA PRA Category 1TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Commercial Support:
This Activity was developed without support from any ineligible company.*The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Note: The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical services is owned, or controlled by, and ACCME defined ineligible company.
Disclosure:
The HCA Healthcare Continental Division is committed to providing CME that is balanced, objective, and evidenced-based. In accordance with the Accreditation Council for Continuing Medical Education Standards for Integrity and Independence all parties involved in content development are required to disclose all conflicts of interest with ACCME defined ineligible companies. The HCA Healthcare Continental Division has identified, reviewed, and mitigated all conflicts of interest that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to the delivery of any educational activity. The CME planning committee who are in a position to control the content of this CME Activity, have no relevant financial relationships with ineligible companies to disclose.
Available Credit
- 7.00 AMA PRA Category 1 Credit™HCA Healthcare Continental Division is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
HCA Healthcare Continental Division designates this for a maximum of 7.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. - 7.00 Attendance
Activity Credit Requirements
To earn credit for this activity, all participants must have an active CME.HealthONEcares.com account and complete the following:
- Participate in the activity.
- Mark your attendance via SMS code.
- Complete the Activity Evaluation.
Important: If you are seeking CME credit, please ensure your profession is accurately listed in your profile to verify your eligibility.
Required Hardware/software
We recommend the following hardware/software to successfully view and complete the contents of this course:
| Recommended Desktop Parameters | For ease of use, we strongly recommend using a desktop computer to complete this course. The following desktop web browsers are compatible with our system: Desktop: Chrome, Internet Explorer, MS Edge, Safari |
| Recommended Mobile Parameters | While not recommended, if you are familiar with completing courses online you may complete this course using a mobile device. For those wishing to complete this activity on Mobile, the following systems are recommended: Apple iPhones and iPad devices on iOS 10 or later |
If you encounter any issues while accessing our courses, please contact [email protected]